Tag: INCR

InterCure Q1 Revenue Increases 3% Sequentially to C$34 Million

InterCure Begins 2022 with Record Breaking First Quarter Financial Results Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million...
- May 16th, 2022 at 6:06 pm

How Cannabis Stock Analysts Have Revised Their Outlooks

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
- February 20th, 2022 at 10:54 am

Global Cannabis Stock Index Declines 21% in Q3

The Global Cannabis Stock Index fell for the seventh consecutive month, declining 12.6% to 45.02: The index, which was down 21.2% in Q3, had 44 qualifying members during the month following the...
- October 1st, 2021 at 10:57 am

Israeli Cannabis Company Canndoc to Go Public via SPAC

  Subversive Announces Qualifying Transaction with InterCure, Israel’s Leading and Fastest-Growing Cannabis Company Combined Company will be led by Chairman and Former Prime Minister of Israel Ehud Barak and...
- January 26th, 2021 at 9:13 am